| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 139, 139-147, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
MF Prescott, CH McBride, J Hasler-Rapacz, J Von Linden and J Rapacz
Research Department, CIBA-GEIGY Corporation, Summit, New Jersey 07901.
The development of atherosclerotic lesions was studied in pigs aged 4 to 54 months with inherited hyperlow-density lipoprotein (LDL) and hypercholesterolemia (IHLC pigs). These pigs bear the Lpb5 and Lpu1 mutant alleles for apolipoproteins B and U and demonstrate spontaneously elevated cholesterol levels, due primarily to elevated LDL. By 1 year of age, IHLC pigs exhibited focal lesions in the major coronary, iliac, and femoral arteries that were composed of macrophage- derived from cells and smooth muscle cells. Peripheral arterial lesions were more fibrous than those found in the coronaries. By 2 years of age, complicated stenotic lesions containing fibrous caps, necrotic cores, cholesterol clefts, granular calcium deposits, and neovascularization deep within the lesion were common in the major coronary vessels. Peripheral vascular lesions were more smooth muscle cell-rich and fibrotic. By 3 years of age, neovascularization was observed throughout the intimal lesion, and hemorrhage and rupture were common. The extent of complicated lesion formation correlated with both the degree and duration of hypercholesterolemia, with the most stenotic lesions observed in the coronary arteries of the oldest animals having the highest cholesterol levels. Thus IHLC pigs with mutant apolipoproteins B and U develop complicated atherosclerotic plaques that closely resemble advanced atherosclerotic lesions found in humans.
This article has been cited by other articles:
 |
|
 |
|
  M. D. Rekhter How to evaluate plaque vulnerability in animal models of atherosclerosis? Cardiovasc Res, April 1, 2002; 54(1): 36 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Muller, P. G. Kaufmann, R. V. Luepker, M. L. Weisfeldt, P. C. Deedwania, and J. T. Willerson Mechanisms Precipitating Acute Cardiac Events : Review and Recommendations of an NHLBI Workshop Circulation, November 4, 1997; 96(9): 3233 - 3239. [Full Text]
|
|
|
|
 |
|
 J. Hasler-Rapacz, H. J. Kempen, H. M.G. Princen, B. J. Kudchodkar, A. Lacko, and J. Rapacz Effects of Simvastatin on Plasma Lipids and Apolipoproteins in Familial Hypercholesterolemic Swine Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 137 - 143. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. M. Schwartz, D. deBlois, and E. R. M. O'Brien The Intima : Soil for Atherosclerosis and Restenosis Circ. Res., September 1, 1995; 77(3): 445 - 465. [Full Text]
|
|
|
|
|
|
J. Hasler-Rapacz, M. F. Prescott, J. Von Linden-Reed, J. M. Rapacz Jr, Z. Hu, and J. Rapacz Elevated Concentrations of Plasma Lipids and Apolipoproteins B, C-III, and E Are Associated With the Progression of Coronary Artery Disease in Familial Hypercholesterolemic Swine Arterioscler. Thromb. Vasc. Biol., May 1, 1995; 15(5): 583 - 592. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Chang, E Barr, J Seltzer, Y. Jiang, G. Nabel, E. Nabel, M. Parmacek, and J. Leiden Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product Science, January 27, 1995; 267(5197): 518 - 522. [Abstract] [PDF]
|
|
|
|
|
|
T Ohno, D Gordon, H San, V. Pompili, M. Imperiale, G. Nabel, and E. Nabel Gene therapy for vascular smooth muscle cell proliferation after arterial injury Science, August 5, 1994; 265(5173): 781 - 784. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
